- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01512524
Hormonal Deficiency in the Quality of Life of Patients With Traumatic Brain Injury (INSPIRE-TC)
Long Term Follow-up of Moderate and Severe Traumatic Bain Injury and Assessment of Involvement of Hormonal Deficiency in the Quality of Life
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Severe Traumatic Brain Injury, when not leading to mortality, is a major cause of morbidity in early adulthood.
Recent studies have demonstrated a previously unappreciated association between Severe Traumatic Brain Injury and endocrine dysfunction.
The current trial aims at evaluating the quality of life 18 months post-trauma and associating this outcome to growth hormone levels.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhône Alpes
-
Lyon, Rhône Alpes, France, 69000
- Recruiting
- French University Hospital
-
Principal Investigator:
- sophie Courtois, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All subjects must be between the ages of 18-65
- Documented moderate to severe Traumatic Brain Injury (TBI) at less than 4 months post injury.
- Glasgow Coma Scale (GCS) equal to or greater than 12
- Patients volunteer to participate in the study, with a written informed consent signed
- BMI between 17 kg/m2 - 30kg/m2
- Affiliation to a national health insurance program
Exclusion Criteria:
- Glasgow Coma Scale (GCS) ≥13
- History of TBI ≥4 months
- Anterior hypopituitarism documented
- History of radiotherapy
- Liver dysfunction: total bilirubin <20µmol/l and/or factor V<60%)
- Renal dysfunction: creatinine clearance < 30 ml/mn (Cockcroft & Gault)
- Anyone who is currently taking or who has taken corticotherapy in the last 4 weeks before TBI
- Pregnancy
- Contraindications to MRI:
- Patients who have a heart pacemaker
- Patients who have a metallic foreign body (metal sliver) in their eye, or who have an aneurysm clip in their brain
- Patients with severe claustrophobia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Patients With Traumatic Brain Injury
Study of the association between quality of life and MRI scans and endocrinology analysis (quantification of Growth Hormone) 18 months post-trauma.
|
Endocrinology analysis including statique and dynamic exams, neuropsychologic evaluations and IRM scan.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evolution of the SF-36(Short-Form health survey)score up to 18 months post-trauma
Time Frame: assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
QOLIBRI (Quality of Life after Brain Injury) measure #1
Time Frame: assessed at 4 months (M4), 12 months (M12)and 18 months (M18) after brain injury.
|
assessed at 4 months (M4), 12 months (M12)and 18 months (M18) after brain injury.
|
|
Questions on Life Satisfaction-Hypopituitarism (QLS-H) measure #2
Time Frame: Time frame: assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
Time frame: assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
|
Tests of Attentional, mnesic and executive performances #3
Time Frame: assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
Tests of Attentional, mnesic and executive performances: - Alertness
|
assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
Functional outcomes (#4):The Glasgow Outcome Scale (GOS)-Score
Time Frame: assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
|
Functional outcome #5 :the Functional Independence Measure (FIM)
Time Frame: assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
assessed at 4 months (M4), 12 months (M12) and 18 months (M18) after brain injury.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sophie Courtois, MD, Hôpital Henry Gabrielle, Hospices Civils de Lyon
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010.641
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Traumatic Brain Injury (TBI)
-
Sheba Medical CenterRecruitingTraumatic Brain Injury (TBI) PatientsIsrael
-
ElMindA LtdAthletico Physical TherapyCompletedMinor Traumatic Brain Injury (TBI)United States
-
ElMindA LtdNoran Neurological ClinicCompletedHealthy | Minor Traumatic Brain Injury (TBI)United States
-
ElMindA LtdYork UniversityCompletedMinor Traumatic Brain Injury (TBI)Canada
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
University of MinnesotaNot yet recruitingTBI (Traumatic Brain Injury)United States
-
Kent State UniversityVirginia Commonwealth UniversityRecruitingTBI (Traumatic Brain Injury)United States
-
Pomeranian Medical University SzczecinCompletedTBI (Traumatic Brain Injury)Poland
-
San Francisco Veterans Affairs Medical CenterVA Office of Research and DevelopmentCompletedTBI (Traumatic Brain Injury)United States
-
University of HelsinkiHelsinki University Central Hospital; University of Virginia; University of Jyvaskyla and other collaboratorsCompletedTraumatic Brain Injury (TBI)Finland
Clinical Trials on MRI scan and endocrinology analysis
-
Robert Jones and Agnes Hunt Orthopaedic and District...Imperial College London; University of Oxford; University of Aberdeen; Keele UniversityCompleted
-
Universitaire Ziekenhuizen KU LeuvenRecruitingPosterior Tibial Tendon DysfunctionBelgium
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR)RecruitingOsteoarthritis | Hip Dysplasia | Femoroacetabular ImpingementCanada
-
Ohio State University Comprehensive Cancer CenterPelontoniaActive, not recruitingProstate Carcinoma | Cardiovascular InjuryUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); North American Brain Tumor ConsortiumCompleted
-
University of ChicagoRecruitingBreast CancerUnited States
-
Maastricht University Medical CenterDiabetes FondsCompletedDiabetes Mellitus, Type 2 | Diabetic CardiomyopathiesNetherlands
-
Jeffrey A. Lieberman, MDTerminated
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)TerminatedSchizophreniaUnited States
-
Radboud University Medical CenterCompletedHead and Neck NeoplasmsNetherlands